This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Herniaria glabra
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
European herb used since antiquity for urinary conditions, hernias, and respiratory complaints; approved in Germany for urinary spasms.
European herb used since antiquity for urinary conditions, hernias, and respiratory complaints; approved in Germany for urinary spasms. Key active compounds include herniarin, umbelliferone, herniaria saponins.
herniarin, along with umbelliferone and herniaria saponins, are the primary bioactive compounds in Rupturewort. These compounds modulates NF-κB and COX-2 inflammatory pathways, disrupts microbial cell membranes and inhibits pathogen growth.
Spasmolytic activity
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-inflammatory effects
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Diuretic properties
Antimicrobial action
Urinary spasms
Based on traditional use; clinical evidence limited
Kidney stones
Based on traditional use; clinical evidence limited
Respiratory conditions
Based on traditional use; clinical evidence limited
Hernias (traditional)
Based on traditional use; clinical evidence limited
Found an error or have a correction for Rupturewort?
Report an Issue →